GAMCO Investors’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Hold |
84,500
| – | – | 0.01% | 752 |
|
|
2025
Q1 | $595K | Sell |
84,500
-1,500
| -2% | -$10.6K | 0.01% | 649 |
|
|
2024
Q4 | $639K | Sell |
86,000
-1,500
| -2% | -$11.1K | 0.01% | 657 |
|
|
2024
Q3 | $431K | Buy |
87,500
+6,300
| +8% | +$31.1K | ﹤0.01% | 715 |
|
|
2024
Q2 | $417K | Buy |
81,200
+5,000
| +7% | +$25.7K | ﹤0.01% | 715 |
|
|
2024
Q1 | $405K | Sell |
76,200
-300
| -0.4% | -$1.59K | ﹤0.01% | 717 |
|
|
2023
Q4 | $474K | Hold |
76,500
| – | – | 0.01% | 694 |
|
|
2023
Q3 | $577K | Hold |
76,500
| – | – | 0.01% | 664 |
|
|
2023
Q2 | $740K | Sell |
76,500
-6,500
| -8% | -$62.9K | 0.01% | 624 |
|
|
2023
Q1 | $313K | Sell |
83,000
-4,000
| -5% | -$15.1K | ﹤0.01% | 751 |
|
|
2022
Q4 | $564K | Buy |
87,000
+8,000
| +10% | +$51.8K | 0.01% | 683 |
|
|
2022
Q3 | $702K | Buy |
79,000
+2,000
| +3% | +$17.8K | 0.01% | 628 |
|
|
2022
Q2 | $768K | Buy |
77,000
+2,000
| +3% | +$19.9K | 0.01% | 628 |
|
|
2022
Q1 | $869K | Buy |
75,000
+2,000
| +3% | +$23.2K | 0.01% | 633 |
|
|
2021
Q4 | $810K | Buy |
73,000
+13,918
| +24% | +$154K | 0.01% | 664 |
|
|
2021
Q3 | $545K | Buy |
59,082
+12,582
| +27% | +$116K | ﹤0.01% | 734 |
|
|
2021
Q2 | $523K | Buy |
+46,500
| New | +$523K | ﹤0.01% | 754 |
|